Jihad A. Mustapha, MD, FACC, FSCAI

Original Research

The Peripheral RegIstry of Endovascular Clinical OutcoMEs (The PRIME Registry): Interim Analysis of the First 328 Subjects with Critical Limb Ischemia

03/15/2017

Sara Finton , BSN;

Carmen Heaney , BSN;

Theresa McGoff , BSN;

Larry J. Diaz-Sandoval , MD;

Fadi Saab , MD, FACC, FSCAI;

Robert E. Beasley , MD, FSCAI, FSIR;

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Jihad A. Mustapha , MD, FACC, FSCAI;

Subjects with critical limb ischemia (CLI) have high 1-year amputation and mortality rates.The clinical profile and outcomes of CLI subjects were characterized using the PRIME registry and compared with previous literature to highlight the...

Subjects with critical limb...

03/15/2017

Vascular Disease Management

CLI Perspectives

Defining CLI From the Front Lines of Care

09/06/2017

Jihad A. Mustapha , MD, FACC, FSCAI;

Eric C. Scott , MD;

In my own practice, I have lowered the threshold to pursue the presence of PAD in patients with non-healing wounds.

In my own practice, I have...

09/06/2017

Cath Lab Digest

Diabetes Watch

Emerging Insights On The Role Of Endovascular Revascularization In Wound Healing And Amputation Prevention

08/11/2019

Vickie R. Driver , DPM, MS, FACFAS;

David O'Connor , MD;

W. Schuyler Jones , MD;

Anthony R. Iorio , DPM, MPH;

Fadi Saab , MD, FACC, FSCAI;

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Ehrin J. Armstrong , MD, MSc, FACC;

Jihad A. Mustapha , MD, FACC, FSCAI;

Lower extremity peripheral artery disease (PAD) has varied manifestations and is categorized according to the Rutherford classification.1,2,3 Claudication progresses from mild to severe in Rutherford categories one through three (RC1–3).

Lower extremity peripheral...

08/11/2019

Podiatry Today

FDA Panel

A View on Drug-Coated Balloons From the Land of the Practicing Physician

06/21/2019

Jihad A. Mustapha , MD, FACC, FSCAI;

Jihad A. Mustapha, MD, comments on the use of drug-coated balloons.

Jihad A. Mustapha, MD, comments...

06/21/2019

Vascular Disease Management

CLI Perspectives

Technologies Built for an Unmet Need: Hostile Arterial Conduits

10/07/2016

Jihad A. Mustapha , MD, FACC, FSCAI;

Robert E. Beasley , MD, FSCAI, FSIR;

In this interview, we showcase how one start-up company is focused on developing not only low profile, but ultra-low profile devices, for this unchartered territory. We, as critical limb ischemia (CLI) therapists, try to deliver the most...

In this interview, we showcase...

10/07/2016

Cath Lab Digest

CLI Perspectives

4 French Access for Endovascular Procedures

07/29/2019

Jihad A. Mustapha , MD, FACC, FSCAI;

William H. Julien , MD;

All arterial punctures are performed with ultrasound guidance and 4 French (Fr) micropuncture.

All arterial punctures are...

07/29/2019

Cath Lab Digest

Clinical Review

Atherectomy and Critical Limb Ischemia: A Treatment Approach for Severely Calcified Vessels

09/30/2013

Barbara Karenko , DO;

Jihad A. Mustapha , MD, FACC, FSCAI;

Fadi Saab , MD, FACC, FSCAI;

Larry J. Diaz-Sandoval , MD;

Atherectomy devices excise, ablate, or modify calcified deposits and plaque, allowing compliance alteration of severely calcified vessels, rendering them more suitable for treatment with balloons and/or stents.

Atherectomy devices excise,...

09/30/2013

Vascular Disease Management

CLI Perspectives

The Exciting Educational Programs and Offerings at VIVA 2015

10/05/2015

Jihad A. Mustapha , MD, FACC, FSCAI;

D. Chris Metzger , MD, FACC;

I first learned about CLI and its implications at VIVA years ago and have watched the evolving education pertaining to CLI growing.

I first learned about CLI and...

10/05/2015

Cath Lab Digest

Roundtable Discussion

A Case Discussion Featuring a Chocolate Balloon in a CLI Patient

04/06/2022

Bryan T. Fisher Sr., MD;

Christopher Metzger , MD;

Jihad A. Mustapha , MD, FACC, FSCAI;

Featuring Jihad A. Mustapha, MD, Bryan T. Fisher, MD, and Christopher Metzger, MD.

Featuring Jihad A. Mustapha, MD,...

04/06/2022

Cath Lab Digest

CLI Perspectives

Desperate Times Require Complex Measures: An AV Reversal Case Study

07/30/2017

Jihad A. Mustapha , MD, FACC, FSCAI;

The time of onset of symptoms to the time the patient presented for the current procedure was over 10 months. Ten months, to a CLI patient, is a lifetime. With no other endovascular or surgical options other than amputation, an...

The time of onset of symptoms to...

07/30/2017

Cath Lab Digest